Effect of single and repeated administration of fluvoxamine on noradrenaline release in rat brain

European Journal of Pharmacology

Volumn 332, Issue 3, 1997, Pages 237-243

  Shachar, Dorit Ben ^a   Klein, Ehud ^a   Tabak, Arek ^a   Finberg, John P M ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

5 HT (hydroxytryptamine, serotonin); Dopamine; Fluvoxamine; Frontal cortex; Microdialysis; Noradrenaline

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPA; DOPAMINE; FLUVOXAMINE; HOMOVANILLIC ACID; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESENCEPHALON; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; FLUVOXAMINE; HIPPOCAMPUS; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 0030846125     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01084-4     Document Type: Article

References (34)

1. Aston-Jones G., Akaoka H., Charlety P., Chouvet G. Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J. Neurosci. 11:1991;760-769.
2. Bel N., Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Eur. J. Pharmacol. 229:1992;101-103.
3. Bel N., Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 15:1993;243-245.
4. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
5. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251:1989;803-809.
6. Blandina P., Goldfarb J., Walcott J., Green J.P. Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J. Pharmacol. Exp. Ther. 256:1991;341-347.
7. 1B receptors. J. Pharmacol. Exp. Ther. 250:1989;37-43.
8. Bosker F.J., Klompmakers A.A., Westenberg H.G.M. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the medial raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology. 34:1995;501-508.
9. Chaput Y., De Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT receptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 333:1986;342-348.
10. Claassen V., Davies J.E., Hertting G., Placheta P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br. J. Pharmacol. 60:1977;505-516.
11. De Deurwaerdere P., Bonhomme N., Lucas G., Le Moal M., Spampinato U. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J. Neurochem. 66:1996;210-215.
12. 2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Br. J. Pharmacol. 107:1992;240-245.
13. Dray A., Davies J., Oakley N.R., Tongroach P., Vellucci S. The dorsal and medial raphe projections to the substantia nigra in the rat: Electrophysiological, biochemical and behavioural observations. Brain Res. 151:1978;431-442.
14. Feuerstein T.J., Hertting G. Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn-Schmiedeberg's Arch. Pharmacol. 333:1986;191-197.
15. Fozard J.R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 23:1984;1473-1486.
16. 3 receptors in drug dependence. Drug Alcohol Depend. 38:1995;155-171.
17. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260:1994;251-255.
18. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol. 9 (Suppl. 1):1994;19-26.
19. Imai H., Steindler D.A., Kitai S. The organisation of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243:1986;363-380.
20. 1A receptors. Eur. J. Pharmacol. 260:1994;243-246.
21. 3H -dopamine via reversal of dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine J. Pharmacol. Exp. Ther. 262:1992;356-364.
22. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res. 513:1990;156-160.
23. 1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum. J. Pharmacol. Exp. Ther. 266:1993;133-141.
24. Kelland M.D., Freeman A.S., Chiodo L.A. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J. Pharmacol. Exp. Ther. 253:1990;803-811.
25. Lamensdorf I., Youdim M.B.H., Finberg J.P.M. The effect of long term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. J. Neurochem. 67:1996;1532-1539.
26. 3H ]noradrenaline in rat brain limbic structures Eur. J. Pharmacol. 256:1994;269-279.
27. Moret C., Briley M. Serotonin autoreceptor subsensitivity and antidepressant activity. Eur. J. Pharmacol. 180:1990;351-356.
28. Moret C., Briley M. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur. J. Pharmacol. 295:1996;189-197.
29. Paxinos, G., Watson, C., 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
30. Pickel V.M., Joh T.H., Reis D. A serotonergic innervation of noradrenergic neurons in locus coeruleus: Demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Res. 131:1977;197-214.
31. 4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo. Br. J. Pharmacol. 117:1996;55-62.
32. Storm-Mathisen J. Localisation of transmitter candidates in the brain: The hippocampal formation as a model. Progr. Neurobiol. 8:1977;119-181.
33. Sturtz F., Rollet D., Faucon Biguet N., Mallet J., Buda M. Long-term alteration in tyrosine hydroxylase mRNA levels in rat locus coeruleus after intraventricular injection of 5,6-dihyroxytryptamine. Brain Res. Mol. Brain Res. 22:1994;107-112.
34. 3[H] -dopamine release from rat striatal synaptosomes Eur. J. Pharmacol. 199:1991;185-189.